Literature DB >> 23143257

Expression, purification, crystallization and preliminary X-ray structure analysis of Vibrio cholerae uridine phosphorylase in complex with thymidine.

Alexander A Lashkov1, Azat G Gabdulkhakov, Igor I Prokofev, Tatyana A Seregina, Sergey E Sotnichenko, Andrey V Lyashenko, Alexander A Shtil, Alexander S Mironov, Christian Betzel, Al'bert M Mikhailov.   

Abstract

A high-resolution structure of the complex of Vibrio cholerae uridine phosphorylase (VchUPh) with its physiological ligand thymidine is important in order to determine the mechanism of the substrate specificity of the enzyme and for the rational design of pharmacological modulators. Here, the expression and purification of VchUPh and the crystallization of its complex with thymidine are reported. Conditions for crystallization were determined with an automated Cartesian Dispensing System using The Classics, MbClass and MbClass II Suites crystallization kits. Crystals of the VchUPh-thymidine complex (of dimensions ∼200-350 µm) were grown by the sitting-drop vapour-diffusion method in ∼7 d at 291 K. The crystallization solution consisted of 1.5 µl VchUPh (15 mg ml(-1)), 1 µl 0.1 M thymidine and 1.5 µl reservoir solution [15%(w/v) PEG 4000, 0.2 M MgCl(2).6H2O in 0.1 M Tris-HCl pH 8.5]. The crystals diffracted to 2.12 Å resolution and belonged to space group P2(1) (No. 4), with unit-cell parameters a=91.80, b=95.91, c=91.89 Å, β=119.96°. The Matthews coefficient was calculated as 2.18 Å3 Da(-1); the corresponding solvent content was 43.74%.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143257      PMCID: PMC3515389          DOI: 10.1107/S1744309112041401

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  25 in total

1.  The X-ray structure of Salmonella typhimurium uridine nucleoside phosphorylase complexed with 2,2'-anhydrouridine, phosphate and potassium ions at 1.86 A resolution.

Authors:  Alexander A Lashkov; Nadezhda E Zhukhlistova; Azat H Gabdoulkhakov; Alexander A Shtil; Roman G Efremov; Christian Betzel; Al'bert M Mikhailov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

2.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

3.  Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources.

Authors:  A K Drabikowska; L Lissowska; Z Veres; D Shugar
Journal:  Biochem Pharmacol       Date:  1987-12-01       Impact factor: 5.858

4.  Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines.

Authors:  Weiming Bu; Ethan C Settembre; Mahmoud H el Kouni; Steven E Ealick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-06-24

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.

Authors:  Z Veres; I Szinai; A Szabolcs; K Ujszászy; G Dénes
Journal:  Drugs Exp Clin Res       Date:  1987

7.  Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase.

Authors:  A K Drabikowska; L Lissowska; M Draminski; A Zgit-Wroblewska; D Shugar
Journal:  Z Naturforsch C J Biosci       Date:  1987-03

8.  Isolation, crystallization and preliminary crystallographic analysis of Salmonella typhimurium uridine phosphorylase crystallized with 2,2'-anhydrouridine.

Authors:  Vladimir I Timofeev; Alexander A Lashkov; Azat G Gabdoulkhakov; Bogdan Ph Pavlyuk; Galina S Kachalova; Christian Betzel; Ekaterina Yu Morgunova; Nadezhda E Zhukhlistova; Al'bert M Mikhailov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-19

9.  Role of uridine phosphorylase in the anabolism of 5-fluorouracil.

Authors:  P M Schwartz; R D Moir; C M Hyde; P J Turek; R E Handschumacher
Journal:  Biochem Pharmacol       Date:  1985-10-01       Impact factor: 5.858

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  Crystallization and preliminary X-ray study of Vibrio cholerae uridine phosphorylase in complex with 6-methyluracil.

Authors:  Igor I Prokofev; Alexander A Lashkov; Azat G Gabdulkhakov; Mariya V Dontsova; Tatyana A Seregina; Alexander S Mironov; Christian Betzel; Al'bert M Mikhailov
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.